TCI Biotech stated that this expansion represents not only a capacity upgrade but also a significant milestone in strengthening its North American operational footprint and localised manufacturing capabilities.
As part of its long-term commitment to the US market, the company will progressively introduce selected production processes to its Utah facility, further advancing supply chain localisation and enhancing operational efficiency.
Currently, the US market contributes approximately 30% of TCI Biotech’s overall revenue.
With new production lines coming online and localised manufacturing capacity continuing to scale, TCI Biotech expects the US market to maintain a double-digit compound annual growth trajectory in the coming years, positioning the region as one of the company’s most important long-term growth engines.
The expansion also underscores TCI Biotech’s commitment to strengthening US manufacturing.
The upgraded facility will feature advanced equipment, highlighted by the launch of its US-based powder sachet production line.
The site is also designed to support future liquid and jelly sachet production, further enhancing manufacturing flexibility and capacity.
Liquid sachets enable convenient, single-dose and ready-to-consume formats that improve product stability and the overall consumer experience.
In parallel, the company plans to expand its clinical research and product development capabilities, with the project expected to create new employment opportunities in the local community.
TCI Biotech currently operates across the United States, China, the Netherlands, Japan, Thailand, India, Vietnam and Indonesia.
This global footprint enables the company to access high-growth markets, shorten supply chain cycles, strengthen collaboration with partners worldwide, and reduce tariff and logistics costs.
Through continued investment in US-based manufacturing and R&D, TCI Biotech aims to further enhance its global one-stop solution capabilities — from natural ingredient development and applied research to product design, production, market promotion and distribution.
All operations adhere to internationally recognised standards, enabling TCI Biotech to deliver greater value to customers and consumers worldwide.